GENPHARMASEC
Back to Balance Sheet
|
GENPHARMASEC Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Total Current Liabilities | ₹9.84 Cr | ₹2.70 Cr | ₹2.06 Cr |
What is the latest Total Current Liabilities ratio of GENPHARMASEC ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹9.84 Cr |
| Mar2024 | ₹2.70 Cr |
| Mar2023 | ₹2.06 Cr |
How is Total Current Liabilities of GENPHARMASEC Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹9.84 Cr | 264.03 | |
| Mar2024 | ₹2.70 Cr | 30.91 | |
| Mar2023 | ₹2.06 Cr | - | |
Compare Total Current Liabilities of peers of GENPHARMASEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENPHARMASEC | ₹68.7 Cr | -1.6% | 36.3% | -41.4% | Stock Analytics | |
| SUDARSHAN CHEMICAL INDUSTRIES | ₹6,992.0 Cr | -1% | 12.8% | -17.6% | Stock Analytics | |
| KIRI INDUSTRIES | ₹2,707.4 Cr | 1.7% | 10.7% | -31.2% | Stock Analytics | |
| VIDHI SPECIALTY FOOD INGREDIENTS | ₹1,480.9 Cr | -6.2% | 5.6% | -31.4% | Stock Analytics | |
| SHREE PUSHKAR CHEMICALS & FERTILISERS | ₹1,233.0 Cr | 5.5% | 22% | 49.2% | Stock Analytics | |
| BODAL CHEMICALS | ₹846.9 Cr | -3% | 17.7% | -0.8% | Stock Analytics | |
GENPHARMASEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENPHARMASEC | -1.6% |
36.3% |
-41.4% |
| SENSEX | -1.3% |
4.6% |
-3.3% |
You may also like the below Video Courses